Evidence map›Paper›PMID 31040128›Full record

ArticleEMBO molecular medicine2019

Control of anterior GRadient 2 (AGR2) dimerization links endoplasmic reticulum proteostasis to inflammation.

Marion Maurel, Joanna Obacz, Tony Avril, Yong-Ping Ding, Olga Papadodima, Xavier Treton, Fanny Daniel, Eleftherios Pilalis, Johanna Hörberg, Wenyang Hou and 19 more

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 100 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 11 institutions in 9 countries.

Marion MaurelINSERM U1242, "Chemistry, Oncogenesis Stress Signaling", University of Rennes, Rennes, France.
Joanna ObaczINSERM U1242, "Chemistry, Oncogenesis Stress Signaling", University of Rennes, Rennes, France.
Tony AvrilINSERM U1242, "Chemistry, Oncogenesis Stress Signaling", University of Rennes, Rennes, France.
Yong-Ping DingINSERM, UMR1149, Team «Gut Inflammation», Research Centre of Inflammation, Paris, France.
Olga PapadodimaInstitute of Biology, Medicinal Chemistry & Biotechnology, NHRF, Athens, Greece.
Xavier TretonINSERM, UMR1149, Team «Gut Inflammation», Research Centre of Inflammation, Paris, France.
Fanny DanielINSERM, UMR1149, Team «Gut Inflammation», Research Centre of Inflammation, Paris, France.
Eleftherios PilalisInstitute of Biology, Medicinal Chemistry & Biotechnology, NHRF, Athens, Greece.
Johanna HörbergDepartment of Chemistry and Molecular Biology, University of Gothenburg, Göteborg, Sweden.
Wenyang HouDepartments of Anatomy and Cell Biology, Human Genetics, and Pediatrics, McGill University, Montreal, QC, Canada.
Marie-Claude BeauchampDepartments of Anatomy and Cell Biology, Human Genetics, and Pediatrics, McGill University, Montreal, QC, Canada.
Julien Tourneur-MarsilleINSERM, UMR1149, Team «Gut Inflammation», Research Centre of Inflammation, Paris, France.
Dominique Cazals-HatemINSERM, UMR1149, Team «Gut Inflammation», Research Centre of Inflammation, Paris, France.
Lucia SommerovaRegional Centre for Applied Molecular Oncology (RECAMO), Brno, Czech Republic.
Afshin SamaliApoptosis Research Centre, School of Natural Sciences, NUI Galway, Galway, Ireland.ORCID 0000-0002-8610-8375
Jan TavernierVIB Department of Medical Protein Research, UGent, Gent, Belgium.
Roman HrstkaRegional Centre for Applied Molecular Oncology (RECAMO), Brno, Czech Republic.
Aurélien DupontMicroscopy Rennes Imaging Centre, and Biosit, UMS3480 CNRS, University of Rennes 1, Rennes Cédex, France.
Delphine FessartUniversity of Bordeaux, Bordeaux, France.
Frédéric DelomUniversity of Bordeaux, Bordeaux, France.
Martin E Fernandez-ZapicoDivision of Oncology Research, Department of Oncology, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN, USA.
Gregor JansenBiochemistry Department, McGill University Life Sciences Complex, Montréal, QC, Canada.ORCID 0000-0002-0289-0022
Leif A ErikssonDepartment of Chemistry and Molecular Biology, University of Gothenburg, Göteborg, Sweden.
David Y ThomasBiochemistry Department, McGill University Life Sciences Complex, Montréal, QC, Canada.
Loydie Jerome-MajewskaDepartments of Anatomy and Cell Biology, Human Genetics, and Pediatrics, McGill University, Montreal, QC, Canada.
Ted HuppInternational Centre for Cancer Vaccine Science, Gdansk, Poland.
Aristotelis ChatziioannouInstitute of Biology, Medicinal Chemistry & Biotechnology, NHRF, Athens, Greece achatzi@eie.gr eric.chevet@inserm.fr eric.ogier-denis@inserm.fr.ORCID 0000-0003-2078-0844
Eric ChevetINSERM U1242, "Chemistry, Oncogenesis Stress Signaling", University of Rennes, Rennes, France achatzi@eie.gr eric.chevet@inserm.fr eric.ogier-denis@inserm.fr.ORCID 0000-0001-5855-4522
Eric Ogier-DenisINSERM, UMR1149, Team «Gut Inflammation», Research Centre of Inflammation, Paris, France achatzi@eie.gr eric.chevet@inserm.fr eric.ogier-denis@inserm.fr.ORCID 0000-0002-0057-7593
Inserm · FRMcGill University · CAUniversité de Bordeaux · FRUniversity of Gothenburg · SECentre National de la Recherche Scientifique · FREdinburgh Cancer Research · GBInternational Hereditary Cancer Center · PLKuehne + Nagel (Greece) · GRMayo Clinic · USOllscoil na Gaillimhe – University of Galway · IEVIB-UGent Center for Medical Biotechnology · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anterior gradient 2 (AGR2) is a dimeric protein disulfide isomerase family member involved in the regulation of protein quality control in the endoplasmic reticulum (ER). Mouse AGR2 deletion increases intestinal inflammation and promotes the development of inflammatory bowel disease (IBD). Although these biological effects are well established, the underlying molecular mechanisms of AGR2 function toward inflammation remain poorly defined. Here, using a protein-protein interaction screen to identify cellular regulators of AGR2 dimerization, we unveiled specific enhancers, including TMED2, and inhibitors of AGR2 dimerization, that control AGR2 functions. We demonstrate that modulation of AGR2 dimer formation, whether enhancing or inhibiting the process, yields pro-inflammatory phenotypes, through either autophagy-dependent processes or secretion of AGR2, respectively. We also demonstrate that in IBD and specifically in Crohn's disease, the levels of AGR2 dimerization modulators are selectively deregulated, and this correlates with severity of disease. Our study demonstrates that AGR2 dimers act as sensors of ER homeostasis which are disrupted upon ER stress and promote the secretion of AGR2 monomers. The latter might represent systemic alarm signals for pro-inflammatory responses.

Indexed as

Endoplasmic Reticulum StressProtein MultimerizationProteostasisAnimalsEndoplasmic ReticulumHEK293 CellsHumansMaleMiceMucoproteinsOncogene ProteinsAGR2 protein, humanAgr2 protein, mouseMucoproteinsOncogene ProteinsAGR2endoplasmic reticuluminflammationproteostasisTMED2

Identifiers

PMID31040128
PMCPMC6554669
OpenAlexW2943758187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.